Actelion drug cuts brain lesions in MS patients | Reuters
Links shared publicly online about this topic.
- 102total visits
Actelion drug cuts brain lesions in MS patients | Reuters
View full resource at reuters.com
Tags: Brain, Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Biotech
Most Recently Shared on August 2, 2011 at 11:00 am By:
Drug cuts brain lesions in MS patients: Actelion study http://reut.rs/qTZCcT
Actelion drug cuts brain lesions in MS patients - Yahoo! News
news.yahoo.com — “Read 'Actelion drug cuts brain lesions in MS patients' on Yahoo! News. ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.” View full resource at news.yahoo.com
Most Recently Shared on August 2, 2011 at 2:15 pm By:
Actelion drug cuts brain lesions in MS patients: ZURICH (Reuters) - Actelion's experimental multiple sclerosis ... http://yhoo.it/nkwIIo
Actelion drug cuts brain lesions in MS patients | Reuters
reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy ride” View full resource at reuters.com
Most Recently Shared on August 2, 2011 at 11:09 am By:
RT @MaureenFierce: Actelion's experimental multiple sclerosis drug ponesimod met main goal in Phase II trial. http://reut.rs/odFNOF
Actelion drug cuts brain lesions in MS patients | Reuters
reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy ride” View full resource at reuters.com
Most Recently Shared on August 2, 2011 at 7:54 am By:
Drug cuts brain lesions in MS patients: Actelion study: ZURICH (Reuters) - Swiss biotech company A... http://bit.ly/nxrPjY #health #news
Actelion drug cuts brain lesions in MS patients | Reuters
reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy ride” View full resource at reuters.com
Most Recently Shared on August 2, 2011 at 6:18 am By:
Drug cuts brain lesions in MS patients: Actelion study: ZURICH (Reuters) - Swiss biotech… http://goo.gl/fb/nG3rE
Actelion drug cuts brain lesions in MS patients | Reuters
reuters.com — “ZURICH (Reuters) - Actelion's experimental multiple sclerosis drug ponesimod met its main goal in a mid-stage trial, giving the Swiss biotech's pipeline a much-needed boost.Actelion has had a bumpy ride” View full resource at reuters.com
Most Recently Shared on August 2, 2011 at 5:53 am By:
RT @MedicalNews Drug cuts brain lesions in MS patients: Actelion study http://bit.ly/re6iDO
Advertisement
